Developments in Ukraine - Joint Society Statement | |
In response to the emerging news from Ukraine, we are very concerned about the neuro-oncology community and the care of patients with brain tumors in that country. Read the joint statement. | |
Glioblastoma Therapeutics Network | |
The National Cancer Institute recently established the Glioblastoma Therapeutics Network (GTN, RFA-CA-20-047). The overall goal of the GTN is to improve the treatment of adult GBM by developing novel effective agents that address known challenges associated with GBM treatment and testing these agents in the clinic. Five multi-institutional U19 Centers (figure) comprise the GTN and aim to move therapeutic agent(s) from pre-clinical development and IND studies to pilot clinical studies in human subjects. A Steering Committee will establish criteria required to move an agent into clinical trials and will assess the readiness of therapeutic candidates from the GTN (or other NIH programs) to enter clinical studies. The Network Coordination Center (NCC) will provide harmonization of GTN administrative, scientific, and clinical functions. Groups from outside of the U19 Centers may become associate members by meeting GTN Steering Committee criteria for therapeutic agent readiness to enter the clinic and by participating in GTN-led clinical trials, subject to budgetary considerations. By engaging GTN members and associate members, NCI intends for the GTN to be a hub for preclinical to clinical transit and for testing of novel agents for adult GBM. For further details, refer to the NCI BSA meeting videocast (May 12, 2020), the associated GTN slide set, and DCTD News and Events. | | |
|
Earn 6.0 hours of AMA PRA Category 1 Credit™️ by reading the recently published Neuro-Oncology Advances Brain Metastases Supplement in its entirety. The supplement’s purpose is to provide neuro-oncology practitioners the latest information on the diagnosis and management of brain metastases | |
Please join us for an exciting webinar titled “The Neural Regulation of Cancer,” jointly sponsored by the Society for Neuro-Oncology and the World Federation of Neurology. The webinar will occur on March 14, 2022, from 9:00-10:00 am EST (2:00-3:00 pm CET). Participants will learn about the role of neuronal activity in glioma progression, the neural regulation of brain metastases, and the similar principles that apply. Click here to register. | |
The Pediatric Special Interest Track is pleased to present the next broadcast of the Pediatric Tumor Board Series. The broadcast entitled Embryonal tumor with multilayered rosettes (ETMR): Evidence-based recommendations for the diagnosis and treatment of this biologically and clinically heterogeneous pediatric CNS tumor will occur live on March 22, 2022, 10:00-11:30 am EST. Click here to register. | |
|
Brought to you by the Wellness Committee of the Society for Neuro-Oncology
4-7-8 Breathing Technique
- Exhale completely through your mouth, making a whoosh sound.
- Close your mouth and inhale quietly through your nose to a mental count of four.
- Hold your breath for a count of seven.
- Exhale completely through your mouth, making a whoosh sound to a count of eight. This is one breath.
- Inhale again and repeat the cycle three more times for a total of four breaths.
Breathing is a natural way to check-in with yourself and maintain balance, utilizing breathing techniques to promote slower breathing can help you prioritize what you may need in certain moments.
| |
SNO Mourns the Passing of Dr. Fred Gentili | |
|
|
This Week's Featured Listing
Spectrum Health is looking to add a full-time, fellowship trained neuro-oncologist to their multi-disciplinary Brain & Spine Tumor Center.
Click here to apply or see other postings!
| | | |
The 20th International Symposium of Pediatric Neuro-Oncology
(ISPNO 2022)
June 12-15, 2022, in Hamburg
Register Here
| |
2nd Annual Conference on Clinical Trials and Brain Metastases
August 12-13, 2022
Call for Abstracts - Deadline: April 18, 2022
Submit Your Abstract
| |
|
2022 SNO Introduction to Clinical Trial Design and Protocol Development Workshop
August 11, 2022
Application deadline - April 15, 2022
Apply Here
| |
SNO is proud to represent over 2,800 professionals committed to driving brain and CNS tumor research and treatment forward with the shared goal of improving outcomes for patients. Through our industry-leading journals, the new Neuro-Oncology Academy, and dynamic educational meetings, members can deepen their understanding and expand their professional network with a SNO membership. Now is the time to renew your membership or join the Society. Click here today to get started. | |
|
SNO Digest is written and distributed by the Society for Neuro-Oncology. All content, including images, may not be reproduced unless permission is granted from SNO. If you would like to contribute to upcoming issues of the SNO Digest or if you have questions, please contact us at snodigest@soc-neuro-onc.org.
| |
Society for Neuro-Oncology | Website | |
| | | |